Search results
AF and Mortality in MI Patients
Author(s):
Ferdinand Bauke
,
Christa Meisinger
,
Philip Raake
,
et al
Added:
1 year ago
Article
Added:
3 months ago
Source:
Radcliffe Cardiology
The long-term utility of beta-blockers following an uncomplicated myocardial infarction (MI) remains a subject of clinical debate. New secondary results from the AβYSS trial (Assessment of β-blocker interruption one Year after an uncomplicated myocardial infarction on Safety and Symptomatic cardiac events requiring hospitalization) reveal that interrupting this therapy leads to sustained…
View more
Author(s):
Rohin K Reddy
,
James P Howard
,
Yousif Ahmad
,
et al
Added:
1 year ago
Author(s):
Harriette Van Spall
,
Tor Biering-Sørensen
Added:
11 months ago
AHA Conference 2024 — New insights from the NUDGE-FLU Program on electronic nudges to increase influenza vaccination amongst patients with a history of myocardial infarction.Dr Harriette Van Spall (McMaster University, CA) sits down with the principal investigator of the NUDGE-FLU trial, (NCT05542004) Dr Tor Biering-Sørensen, to discuss the latest insights and data.NUDGE-FLU is a prospective,…
View more
Author(s):
Ankur Kalra
,
Sukhjinder Nijjer
Added:
1 year ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their…
View more
Author(s):
Yugo Yamashita
Added:
2 years ago
What's hot at the European Society of Cardiology (ESC) Congress 2023?
Browse our curated coverage of the latest updates in cardiology from Amsterdam.
Watch ourView From the Thoraxcenterseries for a concise line up of the most awaited trials fromProf Nicolas Van MieghemandDr Joost Daemen.
For a deeper dive into key clinical trial data and its applicability, host,Dr Harriette Van…
View more
The Year 2023 in Review with Dr Sukh Nijjer
Author(s):
Ankur Kalra
,
Sukhjinder Nijjer
Added:
1 year ago
Podcast Episode
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,…
View more
Author(s):
Mark T Mills
,
Peter Calvert
,
Justin Chiong
,
et al
Added:
1 year ago
ESC 2025 Hot Line & Late-Breaking Science Collection
Video Series